Results 11 to 20 of about 2,542 (110)

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1. [PDF]

open access: yesAm J Hematol
ABSTRACT The clinical significance of PNH Type II white blood cells (WBCs) remains unclear. We assessed the relative percentage (rel%) of Type II neutrophils in 355 patients with a PNH clone ≥ 1% on neutrophils enrolled by 33 flow cytometry laboratories in the 5‐year French nation‐wide multicenter prospective observational study.
Wagner-Ballon O   +24 more
europepmc   +2 more sources

Thrombosis in individuals with high oxygen affinity hemoglobin-associated erythrocytosis: A systematic review and analysis of a national cohort. [PDF]

open access: yesHemasphere
HemaSphere, Volume 10, Issue 9, September 2026.
Laloi M   +19 more
europepmc   +2 more sources

New RHCE*cE allele with c.872C>G and variable RH3 and RH4 phenotypes, predicted to encode p.Pro291Arg. [PDF]

open access: yesTransfusion
Transfusion, Volume 66, Issue 8, Page 1707-1709, August 2026.
Heng E   +5 more
europepmc   +2 more sources

Allele burden expansion in <i>JAK2</i> <sup>V617F</sup> and <i>CALR</i>-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. [PDF]

open access: yesHemasphere
HemaSphere, Volume 10, Issue 9, September 2026.
Ng ZY   +18 more
europepmc   +2 more sources

The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa). [PDF]

open access: yesAm J Hematol
ABSTRACT The predictive value of cytokines (CK) for malignancy‐associated adult hemophagocytic lymphohistiocytosis (M‐HLHa) remains uncertain. We evaluated a cytokine‐based Risk Score (RS) and the IL‐10/IL‐6 Ratio to predict M‐HLHa. Adult patients (n = 112) from the French HLH cohort (NCT02113917) with complete data for nine key HLH related CK measured
Bloch C   +22 more
europepmc   +2 more sources

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells

open access: yesScientific Reports, 2021
Accumulation in target cells is an essential pharmacokinetic step of targeted therapies. Tyrosine Kinase Inhibitors (TKI) against the BCR-ABL fusion protein in Chronic Phase-Chronic Myeloid Leukaemia (CP-CML) cells constitute a unique model in terms of ...
Marc G. Berger   +16 more
doaj   +1 more source

Hématologie du taureau N'Dama

open access: yesRevue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1979
L'auteur rapporte les caractéristiques hématologiques notées lors de l'examen de 10 prélèvements de sang de taureaux N'Dama en provenance de la Côte-d'Ivoire.
L. Chevrier
doaj   +1 more source

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma

open access: yesMedical Sciences, 2023
In primary central nervous system lymphoma, two-year progression-free survival rates of up to 63 percent have been reported for first-line autologous stem cell transplantation after conditioning with the thiotepa busulfan cyclophosphamide regimen ...
Lebon Delphine   +7 more
doaj   +1 more source

Etude de l'hémogramme dans la drépanocytose homozygote: à propos de 87 patients

open access: yesThe Pan African Medical Journal, 2016
La drépanocytose homozygote, fait partie des hémoglobinopathies les plus fréquentes au Maroc. La drépanocytose est caractérisée par une grande variabilité d'expressions clinique et biologique qui dépendent des facteurs génétiques modulateurs et ...
Fatima Dahmani   +5 more
doaj   +1 more source

Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03)

open access: yesClinical Hematology International, 2023
Introduction Despite the implementation of new therapeutic agents, management of relapsed multiple myeloma (MM) remains a challenge. Salvage autologous hematopoietic cell transplant (AHCT) remains a valid therapeutic option for eligible patients who ...
Zoe van de Wyngaert   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy